版本:
中国

BRIEF-OHR Pharmaceutical provides update on ongoing squalamine clinical trial in WET-AMD

April 10 OHR Pharmaceutical Inc:

* OHR Pharmaceutical provides update on ongoing squalamine clinical trial in Wet-Amd

* OHR Pharmaceutical Inc says company now fully funded through efficacy data from ongoing trial and into 2018

* OHR Pharmaceutical Inc says results from ongoing clinical trial in WET-AMD ( MAKO study) expected by end of calendar 2017 or early 2018 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐